Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

GAO: CMS prepared for ICD-10

The General Accounting Office has deemed the Centers for Medicare & Medicaid Services ready to make the switch to ICD-10, reports Clinical Innovation + Technology.

Thumbnail

Groups: Softening ACO rules will not draw more participants

Easing rules around accountable care organizations will not draw in more takers, reports Modern Healthcare. 

Thumbnail

House GOP votes to repeal ACA

The GOP-controlled House passed legislation repealing the Affordable Care Act, with zero Democrats voting in favor of the bill, reports The New York Times.

Rep. Cruz introduces Obamacare Repeal Act

Sen. Ted Cruz (R-Texas) has unveiled an "Obamacare Repeal Act" that would repeal the act "as if such Act had not been enacted," according to the National Review Online. 

White House’s $215M precision medicine initiative ushers in new era in healthcare

The White House announced that it is pumping $215 million into federal health and science agencies so they can develop infrastructure that allows data to flow between medical clinics to labs that sequence the human genome and gather other data, reports Politico.

Thumbnail

NYT editorial: Don’t kill the medical device tax

The Congressional movement to eliminate the 2.3 percent medical device tax is misguided and may do more harm than good, according to an editorial in The New York Times.  

House Energy and Commerce Committee proposal seeks to advance medical treatments

The House Energy and Commerce Committee published a discussion draft of new legislation, called the 21st Century Cures Act, that would promote the development of new medical advances for drugs and medical devices, reports Roll Call. 

Industry coalition backs federal call for value-based care

An industry coalition representing some of the largest healthcare systems and insurers is supporting a Centers for Medicare and Medicaid Services plan to accelerate the movement towards value-based care, reports The New York Times. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup